Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azasite in meibomian gland dysfunction
NCT01797107Phase 2Withdrawn
- Sponsor
- Philadelphia Eye Associates
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin in meibomian gland dysfunction (MGD), sponsored by Philadelphia Eye Associates. Planned start Mar 2013; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT01797107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797107.